Icrom signs a new partnership with NerPharMa – Part of NMS Group, which specializes in the manufacture of oncology drugs.
Together, Icrom and NerPharMa will provide API development and formulary drug production services to third-party companies in increasingly critical areas of oncology and neurology.
For more information👇
